Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 3, 2008, Pages 309-315

  Haston, Christina K ^a   Li, Wei ^b   Li, Ailian ^b   Lafleur, Melanie ^a   Henderson, Janet E ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bone disease; Genetically modified mouse; Lung disease; Preclinical model

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; PARATHYROID HORMONE; SOMATOMEDIN C; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; CYSTIC FIBROSIS; FEMALE; HAPLOTYPE; HISTOPATHOLOGY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; TRABECULAR BONE;

AGE FACTORS; ANIMALS; BONE DISEASES, METABOLIC; CALCIFICATION, PHYSIOLOGIC; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; MALE; MICE; MICE, INBRED CFTR; SEX FACTORS;

EID: 38849119609     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200705-659OC     Document Type: Article

References (30)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-1256.
2. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005;90:1888-1896.
3. McDonnell P, McHugh PE, O'Mahoney D. Vertebral osteoporosis and trabecular bone quality. Ann Biomed Eng 2007;35:170-189.
4. Wehren LE, Siris ES. Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med 2004;256:375-380.
5. Elkin SL, Vedi S, Bord S, Garrahan NJ, Hodson ME, Compston JE. Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 2002;166:1470-1474.
6. Shead EF, Haworth CS, Gunn E, Bilton D, Scott MA, Compston JE. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 2006;174:306-311.
7. Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch J, Lewindon P, Wainwright CE. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 2006;61:146-154.
8. King SJ, Topliss DJ, Kotsimbos T, Nyulasi IB, Bailey M, Ebeling PR, Wilson JW. Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor. Eur Respir J 2005;25:54-61.
9. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC, Vrielynck S, Heuillon B, Azhar I, Cazenave A, Lawson-Body E, Chedevergne F, Lenoir G. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007;175:951-957.
10. Davidson DJ, Rolfe M. Mouse models of cystic fibrosis. Trends Genet 2001;17:S29-S37.
11. Dif F, Marty C, Baudoin C, de Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone 2004;35:595-603.
12. Gawenis LR, Spencer P, Hillman LS, Harline MC, Morris JS, Clarke LL. Mineral content of calcified tissues in cystic fibrosis mice. Biol Trace Elem Res 2001;83:69-81.
13. Snouwaert J, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller B. An animal model for cystic fibrosis made by gene targetting. Science 1992;257:1083-1088.
14. Haston CK, Cory S, Lafontaine L, Dorion G, Hallett MT. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model. Physiol Genomics 2006;25:336-345.
15. Haston CK, Corey M, Tsui LC. Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice. Mamm Genome 2002;13:614-618.
16. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome 2002;13:605-613.
17. Clarke LL, Gawenis LR, Franklin CL, Harline MC. Increased survival of CFTR knockout mice with an oral osmotic laxative. Lab Anim Sci 1996;46:612-618.
18. -/- mice. Hum Mol Genet 2004;13:271-284.
19. Richard S, Torabi N, Franco GV, Tremblay GA, Chen T, Vogel G, Morel M, Cleroux P, Forget-Richard A, Komarova S, et al. Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss. PLoS Genet 2005;1:e74.
20. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-2072.
21. Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. J Cyst Fibros 2004;3:233-236.
22. Haworth CS, Webb AK, Egan JJ, Selby PL, Hasleton PS, Bishop PW, Freemont TJ. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000;118:434-439.
23. Gordon CM, Binello E, LeBoff MS, Wohl ME, Rosen CJ, Colin AA. Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis. Osteoporos Int 2006;17:783-790.
24. Rosenberg LA, Schluchter MD, Parlow AF, Drumm ML. Mouse as a model of growth retardation in cystic fibrosis. Pediatr Res 2006;59:191-195.
25. Delahunty KM, Shultz KL, Gronowicz GA, Koczon-Jaremko B, Adamo ML, Horton LG, Lorenzo J, Donahue LR, Ackert-Bicknell C, Kream BE, et al. Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 2006;147:3915-3923.
26. -/- mice. J Cell Physiol 2004;200:235-244.
27. Lecka-Czernik B, Ackert-Bicknell C, Adamo ML, Marmolejos V, Churchill GA, Shockley KR, Reid IR, Grey A, Rosen CJ. Activation of peroxisome proliferator-activated receptor γ (PPARγ) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology 2007;148:903-911.
28. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001;104:205-215.
29. Kajiya H, Okamoto F, Li JP, Nakao A, Okabe K. Expression of mouse osteoclast K-Cl co-transporter-1 and its role during bone resorption. J Bone Miner Res 2006;21:984-992.
30. Shead EF, Haworth CS, Condliffe AM, McKeon DJ, Scott MA, Compston JE. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 2007;62:650-651.